Radiology Department and Research Center, University of Montreal Medical Center, Hôtel-Dieu Hospital, 3840 Saint-Urbain St, Montréal, QC, Canada H2W 1T8.
Radiology. 2011 Mar;258(3):930-7. doi: 10.1148/radiol.10100636. Epub 2011 Jan 6.
To prospectively compare the effect of intravenous injection of low-osmolar iopamidol with that of intravenous injection of iso-osmolar iodixanol on heart rate (HR) during nongated chest computed tomographic (CT) angiography.
This multicenter study was approved by local institutional review boards, and patients provided written informed consent. Patient enrollment and examination at centers in the United States complied with HIPAA regulations. One hundred and thirty patients (54 male; mean age, 52 years) clinically suspected of having pulmonary embolism were referred for pulmonary CT angiography and were randomly assigned to receive 80 mL of either iopamidol (370 mg of iodine per milliliter, n = 63) or iodixanol (320 mg of iodine per milliliter, n = 67) at a rate of 4 mL/sec. HR (measured in beats per minute) was monitored from 5 minutes before the start of injection to the end of imaging, and precontrast HR and maximum postcontrast HR were recorded. Student t and χ(2) tests were used for continuous and categorical variables, respectively.
Precontrast HR in patients who received iopamidol (mean, 81 beats per minute ± 18 [standard deviation]) was similar to that in patients who received iodixanol (mean, 77 beats per minute ± 17) (P = .16). Mean postcontrast HR was 87 beats per minute ± 17 and 82 beats per minute ± 18 (P = .16) in the iopamidol and iodixanol groups, respectively. Mean increase from precontrast HR to postcontrast HR was 5 beats per minute ± 9 and 5 beats per minute ± 7 (P = .72) in the iopamidol and iodixanol groups, respectively. Thirty-five (56%) of the 63 patients who received iopamidol and 33 (49%) of the 67 patients who received iodixanol had an HR increase of fewer than 5 beats per minute, 15 (24%) and 18 (27%) patients, respectively, had an increase of 5-9 beats per minute, and four (6%) and three (4%) patients, respectively, had an increase of more than 20 beats per minute. These proportions were not significantly different between the groups (P = .51, χ(2) test).
High-rate intravenous administration of 80 mL of iopamidol and iodixanol during pulmonary CT angiography slightly increased HR; there was no difference in HR between the contrast agent groups.
前瞻性比较静脉注射低渗透压碘帕醇和等渗透压碘昔醇对非门控胸部 CT 血管造影时心率(HR)的影响。
本多中心研究经当地机构审查委员会批准,患者均签署书面知情同意书。美国各中心的患者入组和检查均符合 HIPAA 法规。130 例临床疑诊肺动脉栓塞的患者接受肺动脉 CT 血管造影,随机分为两组,分别接受 80mL 碘帕醇(每毫升含 370mg 碘)(n=63)或碘昔醇(每毫升含 320mg 碘)(n=67),注射速度为 4mL/秒。从注射开始前 5 分钟到成像结束,监测 HR(以每分钟跳动次数表示),并记录对比前 HR 和最大对比后 HR。采用 Student t 检验和 χ(2)检验分别对连续变量和分类变量进行分析。
接受碘帕醇治疗的患者(平均 81 次/分±18[标准差])的对比前 HR 与接受碘昔醇治疗的患者(平均 77 次/分±17)相似(P=0.16)。碘帕醇组和碘昔醇组的平均对比后 HR 分别为 87 次/分±17 和 82 次/分±18(P=0.16)。碘帕醇组和碘昔醇组对比前 HR 至对比后 HR 的平均增加量分别为 5 次/分±9 和 5 次/分±7(P=0.72)。63 例接受碘帕醇治疗的患者中有 35 例(56%)和 67 例接受碘昔醇治疗的患者中有 33 例(49%)的 HR 增加少于 5 次/分,分别有 15 例(24%)和 18 例(27%)的患者 HR 增加 5-9 次/分,分别有 4 例(6%)和 3 例(4%)的患者 HR 增加超过 20 次/分。两组间这些比例无显著差异(P=0.51,χ(2)检验)。
在肺动脉 CT 血管造影时静脉内快速注射 80mL 碘帕醇和碘昔醇可轻度增加 HR;两组间 HR 无差异。